DNA Methylation of BRCA1, BRCA2, and TP53 Promoters as Biomarker for the Early Diagnosis of Simian Virus 40-Related Breast Carcinoma

被引：0
|
作者：
Soukayna Alaoui Sosse
Kaoutar Anouar Tadlaoui
Imane Saif
Mustapha Benhassou
Mohamed Elkarroumi
Moulay Mustapha Ennaji
机构：
[1] University Hassan II of Casablanca,Team of Virology, Oncology and Biotechnology, Laboratory of Virology, Oncology, Biosciences, Environment and New Energies, Faculty of Sciences and Techniques‐Mohammedia
[2] University Hassan II of Casablanca,School of Medicine and Pharmacy
来源：
Indian Journal of Gynecologic Oncology | 2024年 / 22卷
关键词：
Breast cancer; Methylation; Viral infection;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] DNA Methylation of BRCA1, BRCA2, and TP53 Promoters as Biomarker for the Early Diagnosis of Simian Virus 40-Related Breast Carcinoma
    Sosse, Soukayna Alaoui
    Tadlaoui, Kaoutar Anouar
    Saif, Imane
    Benhassou, Mustapha
    Elkarroumi, Mohamed
    Ennaji, Moulay Mustapha
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2024, 22 (01)
  • [2] Allelic loss at the BRCA1, BRCA2 and TP53 loci in human sporadic breast carcinoma
    Katsama, A
    Sourvinos, G
    Zachos, G
    Spandidos, DA
    CANCER LETTERS, 2000, 150 (02) : 165 - 170
  • [3] BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma
    Monnerat, Christian
    Chompret, Agnes
    Kannengiesser, Caroline
    Avril, Marie-Francois
    Janin, Nicolas
    Spatz, Alain
    Guinebretiere, Jean-Marc
    Marian, Catalin
    Barrois, Michel
    Boitier, Francois
    Lenoir, Gilbert M.
    Paillerets, Brigitte Bressac-de
    FAMILIAL CANCER, 2007, 6 (04) : 453 - 461
  • [4] BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma
    Christian Monnerat
    Agnès Chompret
    Caroline Kannengiesser
    Marie-Françoise Avril
    Nicolas Janin
    Alain Spatz
    Jean-Marc Guinebretière
    Catalin Marian
    Michel Barrois
    Françoise Boitier
    Gilbert M. Lenoir
    Brigitte Bressac-de Paillerets
    Familial Cancer, 2007, 6 : 453 - 461
  • [5] Germline TP53 mutations in BRCA1 and BRCA2 mutation-negative french canadian breast cancer families
    Arcand, Suzanna L.
    Maugard, Christine M.
    Ghadirian, Parviz
    Robidoux, Andre
    Perret, Chantal
    Zhang, Phil
    Fafard, Eve
    Mes-Masson, Anne-Marie
    Foulkes, William D.
    Provencher, Diane
    Narod, Steven A.
    Tonin, Patricia N.
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 108 (03) : 399 - 408
  • [6] Germline TP53 mutations in BRCA1 and BRCA2 mutation-negative French Canadian breast cancer families
    Suzanna L. Arcand
    Christine M. Maugard
    Parviz Ghadirian
    André Robidoux
    Chantal Perret
    Phil Zhang
    Eve Fafard
    Anne-Marie Mes-Masson
    William D. Foulkes
    Diane Provencher
    Steven A. Narod
    Patricia N. Tonin
    Breast Cancer Research and Treatment, 2008, 108 : 399 - 408
  • [7] Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients
    Daphne SC Lee
    Sook-Yee Yoon
    Lai Meng Looi
    Peter Kang
    In Nee Kang
    Kavitta Sivanandan
    Hany Ariffin
    Meow Keong Thong
    Kin Fah Chin
    Nur Aishah Mohd Taib
    Cheng-Har Yip
    Soo-Hwang Teo
    Breast Cancer Research, 14
  • [8] BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinoma
    McAlpine, Jessica N.
    Porter, Henry
    Koebel, Martin
    Nelson, Brad H.
    Prentice, Leah M.
    Kalloger, Steve E.
    Senz, Janine
    Milne, Katy
    Ding, Jiarui
    Shah, Sohrab P.
    Huntsman, David G.
    Gilks, C. Blake
    MODERN PATHOLOGY, 2012, 25 (05) : 740 - 750
  • [9] Promoter methylation patterns of ATM, ATR, BRCA1, BRCA2 and P53 as putative cancer risk modifiers in Jewish BRCA1/BRCA2 mutation carriers
    Kontorovich, Tair
    Cohen, Yoram
    Nir, Uri
    Friedman, Eitan
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 116 (01) : 195 - 200
  • [10] Genetic, Surgical and Oncological Approach to Breast Cancer, with BRCA1, BRCA2, CDH1, PALB2, PTEN and TP53 Variants
    Subasioglu, Asli
    Guc, Zeynep Gulsum
    Gur, Emine Ozlem
    Tekindal, Mustafa Agah
    Atahan, Murat Kemal
    EUROPEAN JOURNAL OF BREAST HEALTH, 2023, 19 (01) : 55 - 69
12345